Workflow
IT
icon
Search documents
VirTra Sets Second Quarter 2025 Conference Call for Monday, August 11, 2025 at 4:30 p.m. ET
Globenewswire· 2025-07-28 20:05
CHANDLER, Ariz., July 28, 2025 (GLOBE NEWSWIRE) -- VirTra, Inc. (Nasdaq: VTSI) (“VirTra” or the “Company”), a global provider of judgmental use of force training simulators and firearms training simulators for the law enforcement and military markets, will hold a conference call on Monday, August 11, 2025 at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss its financial results for the second quarter ended June 30, 2025. Financial results will be issued in a press release prior to the call. VirTra ...
Investors in Neogen Corporation Should Contact Levi & Korsinsky Before September 16, 2025 to Discuss Your Rights – NEOG
GlobeNewswire News Room· 2025-07-28 20:04
NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Neogen Corporation ("Neogen Corporation" or the "Company") (NASDAQ: NEOG) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Neogen Corporation investors who were adversely affected by alleged securities fraud between January 5, 2023 and June 3, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/neogen ...
Petco Health and Wellness Company, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. August 29, 2025 Deadline to file Lead Plaintiff Motion
GlobeNewswire News Room· 2025-07-28 20:03
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, July 28, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Petco Health and Wellness Company, Inc. ("Petco" or the "Company") (NASDAQ: WOOF) investors of a class action representing investors that bought securities between January 14, 2021 and June 5, 2025, inclusive (the "Class Period"). Petco investors have until August 29, 2025 to file a lead plaintiff motion. Investors are encouraged to contact att ...
ROSEN, A LONGSTANDING FIRM, Encourages Alto Neuroscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ANRO
GlobeNewswire News Room· 2025-07-28 20:03
NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Alto Neuroscience, Inc. (NYSE: ANRO): (i) pursuant and/or traceable to Alto’s initial public offering conducted on or about February 2, 2024 (the “IPO”); and/or (ii) securities between February 2, 2024 and October 22, 2024, both dates inclusive (the “Class Period”). If you wish to serve as lead plaintiff, you must move ...
Gibson Energy Reports 2025 Second Quarter Results, Including Record Volumes at Gateway Following Dredging Completion
Globenewswire· 2025-07-28 20:01
All financial figures are in Canadian dollars unless otherwise noted CALGARY, Alberta, July 28, 2025 (GLOBE NEWSWIRE) -- Gibson Energy Inc. (TSX:GEI) ("Gibson" or the "Company") announced today its financial and operating results for the three and six months ended June 30, 2025. Key Highlights: Generated strong Infrastructure Adjusted EBITDA(1) of $153 million, underscoring the excellent performance of our core business despite planned downtime associated with replacement and growth capital projectsComplete ...
Metsera Reports Second Quarter 2025 Financial Results and Continued Portfolio Progress
Globenewswire· 2025-07-28 20:01
MET-097i (fully biased once-monthly GLP-1 RA) VESPER-1 and interim VESPER-3 data release expected in September 2025; Phase 3 initiation on track for late 2025 MET-233i (once-monthly amylin analog) delivered class-leading Phase 1 results including 8.4% five-week weight loss and 19-day half-life; 12-week monotherapy data expected in late 2025 MET-233i + MET-097i 12-week co-administration data expected by year-end 2025 or early 2026 Oral peptide programs on track; four-week data for selected lead (MET-097o or ...
Fulcrum Therapeutics to Present Results from the 12 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease
Globenewswire· 2025-07-28 20:01
CAMBRIDGE, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Fulcrum) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, will host a conference call and webcast on Tuesday, July 29, 2025 beginning at 8:00 a.m. ET to present topline results from the 12 mg dose cohort of the Phase 1b PIONEER trial of pociredir in sickle cell disease. Members of Fulcrum management will be j ...
FI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Fiserv, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire News Room· 2025-07-28 20:00
NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Fiserv, Inc. (“Fiserv” or “the Company”) (NYSE: FI) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Fiserv securities be ...
X @Ash Crypto
Ash Crypto· 2025-07-28 19:58
BITCOIN DOMINANCE BEARISH CROSS 🚨Bitcoin dominance has formed a bearish cross on 3W timeframe.Also, Bitcoin dominance has lost its 3-year uptrend. This is the biggest sign of an Altseason and upcoming parabolic pump https://t.co/LuRHZfheZB ...
X @Crypto Rover
Crypto Rover· 2025-07-28 19:58
Global liquidity is soaring.Bitcoin still needs to catch up.It’s 83% correlated with the Global liquidity.So basically, it’s just a matter of time! https://t.co/WDknGKljIz ...